“To earn the trust of the medical fraternity and patients through concern, care and cure”.
Canducid- Caspofungin acetate 50 & 70 mg
…Unique action trusted efficacy
  • Provides Convenience of OD dosing.
  • Economical choice
  • Good safety profile
CANDUCID is an echinocandin antifungal drug indicated in adults and Pediatric patients (3 months and older) for:

  • Empirical therapy for presumed fungal infections in febrile, neutropenic patients.
  • Treatment of candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
  • Treatment of esophageal candidiasis.
  • Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies (e.g., amphotericin B, lipid formulations of amphotericin B, itraconazole).

  • Administer by slow intravenous (IV) infusion over approximately 1 hour.
  • Not for IV bolus administration.
  • Do not mix or co-infuse CANDUCID with other medications. Do not use diluents containing dextrose (a-D-glucose).

Adults [18 years of age]:
  • Administer a single 70-mg loading dose on Day 1, followed by 50 mg once daily for all indications except esophageal candidiasis.
  • For esophageal candidiasis, use 50 mg once daily with no loading dose.

Pediatric Patients [3 months to 17 years of age]:
  • Dosing should be based on the patient’s body surface area.
  • For all indications, administer a single 70-mg/m2 loading dose on Day 1, followed by 50 mg/m2 once daily thereafter.
  • Maximum loading dose and daily maintenance dose should not exceed 70 mg, regardless of the patient's calculated dose.
Copyrights @ 2012 : Zyphar's Pharmaceutics